Rep. Marjorie Taylor Greene Purchases Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Key Points

• Representative Marjorie Taylor Greene purchased shares of UnitedHealth Group (NYSE:UNH) valued between $1,001 and $15,000 on August 28th.
• UnitedHealth Group's recent quarterly earnings revealed an EPS of $4.08, missing analyst expectations of $4.45, despite a revenue increase of 12.9% year-over-year.
• The company declared a $2.21 quarterly dividend, payable on September 23rd, reflecting an annualized dividend yield of 2.9%.

Representative Marjorie Taylor Greene (R-Georgia) recently bought shares of UnitedHealth Group Incorporated NYSE: UNH. In a filing disclosed on August 29th, the Representative disclosed that they had bought between $1,001 and $15,000 in UnitedHealth Group stock on August 28th.

Representative Marjorie Taylor Greene also recently made the following trade(s):

• Purchased $1,001 - $15,000 in shares of Southern NYSE: SO on 8/28/2025.
• Purchased $1,001 - $15,000 in shares of Merck & Co., Inc. NYSE: MRK on 8/28/2025.
• Purchased $1,001 - $15,000 in shares of PepsiCo NASDAQ: PEP on 8/28/2025.
• Purchased $1,001 - $15,000 in shares of Morgan Stanley NYSE: MS on 8/28/2025.
• Purchased $1,001 - $15,000 in shares of Novo Nordisk A/S NYSE: NVO on 8/28/2025.
• Purchased $15,001 - $50,000 in shares of Exelon NASDAQ: EXC on 8/28/2025.
• Purchased $15,001 - $50,000 in shares of Ryman Hospitality Properties NYSE: RHP on 8/28/2025.
• Purchased $1,001 - $15,000 in shares of Alphabet NASDAQ: GOOG on 8/28/2025.
• Purchased $1,001 - $15,000 in shares of MercadoLibre NASDAQ: MELI on 8/28/2025.
• Purchased $1,001 - $15,000 in shares of United Parcel Service NYSE: UPS on 8/28/2025.

UnitedHealth Group Trading Up 2.5%

Shares of NYSE:UNH opened at $309.77 on Tuesday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The company has a market capitalization of $280.55 billion, a PE ratio of 13.42, a P/E/G ratio of 2.00 and a beta of 0.44. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73. The business's fifty day simple moving average is $288.34 and its 200-day simple moving average is $378.14.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same period in the previous year, the business earned $6.80 EPS. The firm's revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be issued a $2.21 dividend. The ex-dividend date is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.9%. UnitedHealth Group's dividend payout ratio (DPR) is currently 38.30%.

Insiders Place Their Bets

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the sale, the chief executive officer directly owned 10,398 shares in the company, valued at $3,171,390. This trade represents a 5.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.28% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in UNH. Citizens National Bank Trust Department boosted its position in shares of UnitedHealth Group by 1.0% during the first quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate's stock worth $9,368,000 after buying an additional 170 shares during the period. Fort Washington Investment Advisors Inc. OH boosted its position in shares of UnitedHealth Group by 0.3% during the first quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate's stock worth $277,641,000 after buying an additional 1,465 shares during the period. Caitlin John LLC raised its stake in shares of UnitedHealth Group by 14.8% in the first quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate's stock valued at $451,000 after acquiring an additional 111 shares in the last quarter. Sherbrooke Park Advisers LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at $515,000. Finally, Full Sail Capital LLC raised its stake in shares of UnitedHealth Group by 2.1% in the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate's stock valued at $815,000 after acquiring an additional 33 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities analysts have recently issued reports on UNH shares. Barclays reissued an "overweight" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Deutsche Bank Aktiengesellschaft reduced their price target on UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a report on Wednesday, May 14th. Truist Financial reduced their price target on UnitedHealth Group from $360.00 to $345.00 and set a "buy" rating for the company in a report on Wednesday, July 16th. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $440.00 price target on shares of UnitedHealth Group in a report on Tuesday, August 26th. Finally, Baird R W cut UnitedHealth Group from a "hold" rating to a "strong sell" rating in a report on Thursday, July 31st. Fifteen analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $353.00.

About Representative Greene

Marjorie Taylor Greene (Republican Party) is a member of the U.S. House, representing Georgia's 14th Congressional District. She assumed office on January 3, 2021. Her current term ends on January 3, 2027. Greene (Republican Party) is running for re-election to the U.S. House to represent Georgia's 14th Congressional District. She declared candidacy for the 2026 election.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.